Axovant craters after discontinuing dementia candidate

Axovant Sciences Ltd. (NASDAQ:AXON) sank $3.06 (57%) to $2.31 on Monday after discontinuing development of intepirdine (RVT-101),

Read the full 176 word article

User Sign In